🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the effectiveness and safety of implementing a ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07684469
Treatments Being Tested
This is a pivotal phase III study designed to evaluate safety, tolerability...
Status
Recruiting
Location
UC San Francisco Medical Center
Start Date
2024-12-09
Trial ID
NCT06597019
Treatments Being Tested
This study aims to evaluate the long-term adherence and persistence to incl...
Status
Recruiting
Location
Novartis
Start Date
2026-04-02
Trial ID
NCT07543731
This study was a Phase III,A two-part (double-blind placebo-controlled/open...
Status
Completed
Location
(50852-001) Queen Mary Hospital
Start Date
2019-02-06
Trial ID
NCT03851705
Treatments Being Tested
This was a placebo-controlled, double-blind, randomized trial in Japanese p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-01-29
Trial ID
NCT04666298
Treatments Being Tested
CKJX839D12303 is a research study to determine if the study treatment, call...
Status
Active Not Recruiting
Location
Heart Center Research Llc
Start Date
2022-07-08
Trial ID
NCT05360446
Treatments Being Tested
This was a single-center, retrospective, observational study (non-intervent...
Status
Completed
Location
Novartis
Start Date
2024-04-30
Trial ID
NCT06595069
This study is a Phase II, placebo-controlled, double-blind, randomized tria...
Status
Completed
Location
Jacksonville Center for Clinical Research
Start Date
2016-01
Trial ID
NCT02597127
Treatments Being Tested
The purpose of this study was to evaluate the implementation of inclisiran ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-07
Trial ID
NCT04807400
Treatments Being Tested
This is a Phase III, placebo-controlled, double-blind, randomized study in ...
Status
Completed
Location
Site 90001-005
Start Date
2017-11-28
Trial ID
NCT03397121
Treatments Being Tested